bigpharma

KV Pharmaceutical got the exclusive right to market Makena, a hydroxyprogesterone caproate injection to prevent premature births, and then jacked price from $10 to $1500 a shot. It is now trying to stop compounding pharmacies from making it. The news article says: "By receiving 'orphan drug...